V940 Individualized Neoantigen Therapy (Merck and Moderna) for Melanoma
V940 is an investigational messenger ribonucleic acid (mRNA)-based individualized melanoma vaccine.
Complete this form to request the full report.
Hayes Report Sale Policy: Hayes will review your request to purchase a report and respond to you. Individuals requesting reports due to a payment denial should contact the involved health insurer for details and information.
Please contact us if you are interested in a Hayes subscription.
